Deutsch Intern
Institute for Clinical Epidemiology and Biometry

Felipe A. Montellano

Research in cooperation with the Interdisciplinary Center for Clinical Research at the University of Würzburg / Research within the Clinician-Scientist Programme UNION –CVD (German Research Foundation)

 

Dr. med. Felipe A. Montellano

Phone: +49 931 / 201 47318
Fax: +49 931 / 201 647310
E-Mail: montellano_f@ukw.de

 

Short CV

since 2020 Resident. Department of Neurology, Würzburg University Hospital
since 2017   Research Asssociate. Institute of Clinical Epidemiology and Biometry of the University of Würzburg (MD/PhD Fellow of the Interdisciplinary Center for Clinical Research at the Würzburg University Hospital)
since 2016 European Master in Stroke Medicine. Danube-University Krems. Austria (Scholar of the European Stroke Organisation)
2015-2017 Medical Doctoral Studies. Institute of Physiology and Pathophysiology. Neurovascular Research Group. Medical Faculty of the University of Heidelberg. (Prof. Dr. Hugo Marti)
2014-2015 Resident in Emergency Medicine, Clínica Dávila and Clínica INDISA. Santiago, Chile.
2009 Honours Scholarship, Faculty of Medicine of the Universidad de los Andes. Santiago, Chile
2007-2013 Medical School. Faculty of Medicine of the Universidad de los Andes. Santiago, Chile.

Research interests

Acute stroke therapy, neurocritical care, emergency medicine.

Main Publications in recent years

2024[ to top ]
  • 1.
    Hartung TJ, Bahmer T, Chaplinskaya-Sobol I, Deckert J, Endres M, Franzpötter K, et al. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study. eClinicalMedicine [Internet]. 2024;69:102456. Available from: https://www.sciencedirect.com/science/article/pii/S258953702400035X
  • 1.
    Vollmuth C, Fiessler C, Montellano FA, Kollikowski AM, Essig F, Oeckl P, et al. Incremental value of serum neurofilament light chain and glial fibrillary acidic protein as blood-based biomarkers for predicting functional outcome in severe acute ischemic stroke. Eur Stroke J. 2024;:23969873241234436.
  • 1.
    Montellano FA, Rücker V, Ungethüm K, Penalba A, Hotter B, Giralt M, et al. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies. Eur Stroke J. 2024;:23969873241250272.
2023[ to top ]
  • 1.
    Winkelmann S, Korth A, Voss B, Nasr MA, Behrend N, Pudszuhn A, et al. Persisting chemosensory dysfunction in COVID-19 - a cross-sectional population-based survey. Rhinology. 2023;61(1):12-23.
  • 1.
    Horn A, Jírů-Hillmann S, Widmann J, Montellano FA, Salmen J, Pryss R, et al. Systematic review on the effectiveness of mobile health applications on mental health of breast cancer survivors. Journal of Cancer Survivorship [Internet]. 2023;. Available from: https://doi.org/10.1007/s11764-023-01470-6
  • 1.
    Shi Y, Strobl R, Apfelbacher C, Bahmer T, Geisler R, Heuschmann P, et al. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort. Infection. 2023;:1-16.
2022[ to top ]
  • 1.
    Mishra A, Malik R, Hachiya T, Jürgenson T, Namba S, Posner DC, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611(7934):115-23.
  • 1.
    Mishra A, Malik R, Hachiya T, Jürgenson T, Namba S, Posner DC, et al. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries. Nature [Internet]. 2022;612(7938):E7-E7. Available from: https://doi.org/10.1038/s41586-022-05492-5
  • 1.
    Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549.
  • 1.
    Montellano FA, Kluter EJ, Rücker V, Ungethüm K, Mackenrodt D, Wiedmann S, et al. Cardiac dysfunction and high-sensitive C-reactive protein are associated with troponin T elevation in ischemic stroke: insights from the SICFAIL study. BMC Neurology [Internet]. 2022;22(1):511. Available from: https://doi.org/10.1186/s12883-022-03017-1
  • 1.
    Hartung TJ, Neumann C, Bahmer T, Chaplinskaya-Sobol I, Endres M, Geritz J, et al. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study. eClinicalMedicine [Internet]. 2022;53:101651. Available from: https://www.sciencedirect.com/science/article/pii/S2589537022003819
2021[ to top ]
  • 1.
    Seyhan M, Ungethüm K, Schuhmann MK, Mackenrodt D, Rücker V, Montellano FA, et al. Feasibility of platelet marker analysis in ischemic stroke patients and their association with one-year outcome. A pilot project within a subsample of the Stroke Induced Cardiac Failure in Mice and Men (SICFAIL) cohort study. Platelets [Internet]. 2021;33(5):772-80. Available from: https://doi.org/10.1080/09537104.2021.2002834
  • 1.
    Montellano FA, Ungethüm K, Ramiro L, Nacu A, Hellwig S, Fluri F, et al. Role of Blood-Based Biomarkers in Ischemic Stroke Prognosis: A Systematic Review. Stroke. 2021;52(2):543-51.
  • 1.
    Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • 1.
    Heuschmann PU, Montellano FA, Ungethüm K, Rücker V, Wiedmann S, Mackenrodt D, et al. Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study. ESC Heart Failure [Internet]. 2021;8(2):1117-29. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ehf2.13145